| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6069084 | The Journal of Allergy and Clinical Immunology: In Practice | 2015 | 5 Pages |
Abstract
The risk of overdose and adverse CV events is significantly higher with IV bolus epinephrine administration. Analysis of the data supports the safety of IM epinephrine and a need for extreme caution and further education about IV bolus epinephrine in anaphylaxis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ronna L. MD, PhD, M. Fernanda MD, MS, Benjamin D. MD, Venkatesh R. MD, Martin G. MD, MHA, MBA, David M. MD, MS, Erik P. MD, MSc,